Minister of economic affairs-
designate Lee Chih-kung (李世光) yesterday compared the impact of the OBI Pharma Inc (台灣浩鼎) controversy on the nation’s biotechnology industry to a “tsunami.”
OBI Pharma “definitely has an influence” on the biotech industry, Lee said during an interview with radio host Clara Chou (周玉蔻).
Photo: Huang Pei-chun, Taipei Times
“The impact looks like the beginning of a tsunami,” he added.
Lee said it was hard to say how long it would take for the industry to recover from the scandal, sparked by allegations of insider trading and conflict of interest at OBI Pharma, adding that it would depend on public sentiment.
Most developed countries value the biotech industry and understand that it requires long-term investment, he said.
“I am not trying to speak for OBI Pharma. The insider trading and conflict of interest allegations are indeed significant issues, but I think the public should seek the truth and look at the matter rationally,” Lee told reporters after the interview.
Lee declined to comment on Academia Sinica President Wong Chi-huey’s (翁啟惠) role in the case, saying that Wong should explain the matter to the public.
Wong is an internationally renowned academic, Lee said, adding that he does not think Wong’s involvement in the controversy is a “shame.”
However, the scandal and its effect on the public have affected the reputation of Academia Sinica, he said.
Local media reports have also revealed that Lee’s younger brother, Howard Lee (李世仁), is an independent board member of OBI Pharma and a member of Academia Sinica’s research and development results management committee — sparking a new round of speculation about conflict of interest.
C.K. Lee said that his brother’s situation cannot be classified as a conflict of interest, because the committee does not deal with individual companies.
Moreover, his brother does not receive remuneration as committee member, only a transportation allowance of NT$1,000 to NT$2,000 each time, C.K. Lee said.
However, he has asked his brother to consider resigning from OBI Pharma and the committee given his ministry post.
C.K. Lee also confirmed that he has dual citizenship, but said he had submitted an application to the American Institute in Taiwan (AIT) to give up his US citizenship, with an interview scheduled next week.
C.K. Lee, who is to take up his new post on May 20, is to visit Minister of Economic Affairs John Deng (鄧振中) on Monday to talk about the handover, the ministry said.
The 56-year-old said his biggest challenges in his new post would be finding ways to boost economic development, increase wages for young people and attract international talent to Taiwan.
His first task when he assumes office will be to promote development of the green energy sector in Taiwan in the hope of building a demand-oriented industry as soon as possible, Lee said.
He said he will also push for reform of the industrial sector, which has complained of water, electricity, land, and labor shortages.
Lee said he was made aware of the problems during his tour on April 28 of various industrial and commercial enterprises, which also mentioned other problems such as limited access to funding and consultancy services.
Additional reporting by CNA
State-run CPC Corp, Taiwan (CPC, 台灣中油) yesterday signed a letter of intent with Alaska Gasline Development Corp (AGDC), expressing an interest to buy liquefied natural gas (LNG) and invest in the latter’s Alaska LNG project, the Ministry of Economic Affairs said in a statement. Under the agreement, CPC is to participate in the project’s upstream gas investment to secure stable energy resources for Taiwan, the ministry said. The Alaska LNG project is jointly promoted by AGDC and major developer Glenfarne Group LLC, as Alaska plans to export up to 20 million tonnes of LNG annually from 2031. It involves constructing an 1,290km
NEXT GENERATION: The company also showcased automated machines, including a nursing robot called Nurabot, which is to enter service at a Taichung hospital this year Hon Hai Precision Industry Co (鴻海精密) expects server revenue to exceed its iPhone revenue within two years, with the possibility of achieving this goal as early as this year, chairman Young Liu (劉揚偉) said on Tuesday at Nvidia Corp’s annual technology conference in San Jose, California. AI would be the primary focus this year for the company, also known as Foxconn Technology Group (富士康科技集團), as rapidly advancing AI applications are driving up demand for AI servers, Liu said. The production and shipment of Nvidia’s GB200 chips and the anticipated launch of GB300 chips in the second half of the year would propel
‘MAKE OR BREAK’: Nvidia shares remain down more than 9 percent, but investors are hoping CEO Jensen Huang’s speech can stave off fears that the sales boom is peaking Shares in Nvidia Corp’s Taiwanese suppliers mostly closed higher yesterday on hopes that the US artificial intelligence (AI) chip designer would showcase next-generation technologies at its annual AI conference slated to open later in the day. The GPU Technology Conference (GTC) in California is to feature developers, engineers, researchers, inventors and information technology professionals, and would focus on AI, computer graphics, data science, machine learning and autonomous machines. The event comes at a make-or-break moment for the firm, as it heads into the next few quarters, with Nvidia CEO Jensen Huang’s (黃仁勳) keynote speech today seen as having the ability to
WAIT-AND-SEE: Last month’s consumer price index came in at 2.8%, which boosts expectations that the Fed would proceed cautiously to lower inflation sustainably The US Federal Reserve is widely expected to keep interest rates unchanged at its policy meeting this week, treading carefully amid uncertainty over US President Donald Trump’s economic policies, which include spending cuts and sweeping tariffs. Since January, Trump has imposed levies on major trading partners Canada, Mexico and China, and on steel and aluminum imports, roiling financial markets and fanning fears that his plans could tip the world’s biggest economy into a recession. The Trump administration has also embarked on unprecedented cost-cutting efforts that target staff and spending, while the US president has promised tax reductions and deregulation down the road. However,